Photobiomodulation Enhances Memory Processing in Older Adults with Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy Study.
Agnes S Chan, Tsz-Lok Lee, Michael R Hamblin...
https://pubmed.ncbi.nlm.nih.gov/33998541/Actively Recruiting
Led by Uskudar University · Updated on 2025-12-17
60
Participants Needed
2
Research Sites
39 weeks
Total Duration
Researchers are evaluating whether transcranial photobiomodulation t-PBM, a light-based brain therapy, can improve memory and thinking skills in older adults with amnestic mild cognitive impairment aMCI. This condition involves memory problems greater than normal aging and may increase the risk of Alzheimers disease. The study also aims to see if t-PBM changes how brain areas communicate, especially within the default mode network DMN. Participants will be randomly assigned to receive either active t-PBM or a sham inactive version, both combined with cognitive training. Each participant will take part in eight 20-minute sessions where the device is placed on the head during cognitive exercises. The active device delivers near-infrared light at gamma frequency, while the sham device looks and sounds the same but does not emit therapeutic light. The cognitive rehabilitation program involves pen-and-paper tasks targeting attention, memory, executive function, and language, with difficulty increasing over sessions. Participants will provide a blood sample for genetic testing and undergo brain fMRI scans before and after the 4-week intervention to measure brain connectivity changes. They will also complete cognitive tests and meet with a dietitian at the start and end of the study to monitor diet stability. Researchers will measure changes in cognitive abilities using the Montreal Cognitive Assessment MoCA and changes in brain network connectivity using resting-state fMRI. The study includes monitoring of genetic factors to explore how they might influence treatment responses.
CONDITIONS
Effects of Photobiomodularion on Brain Connectivity and Cognitive Function in Cognitive Impairment
S
Shams Farhad, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Uskudar University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Approximately 4 weeks
Participants receive 8 sessions of transcranial photobiomodulation (either active or sham) combined with cognitive rehabilitation exercises.
8 visits (in-person, 20 minutes each)
Duration - Immediately following the 8-session intervention
Participants undergo cognitive assessments, resting-state fMRI scans, dietitian visits, and genetic analyses to evaluate changes in brain connectivity and cognitive performance after treatment.
2 visits (in-person) including cognitive and imaging assessments and dietitian visit
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Agnes S Chan, Tsz-Lok Lee, Michael R Hamblin...
https://pubmed.ncbi.nlm.nih.gov/33998541/Uskudar University
Lead Sponsor